Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Colostrinin-driven neurite outgrowth requires p53 activation in PC12 cells.

Bacsi A, Stanton GJ, Hughes TK, Kruze M, Boldogh I.

Cell Mol Neurobiol. 2005 Nov;25(7):1123-39.

PMID:
16392041
2.

Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum.

Boldogh I, Liebenthal D, Hughes TK, Juelich TL, Georgiades JA, Kruzel ML, Stanton GJ.

J Mol Neurosci. 2003 Apr;20(2):125-34.

PMID:
12794306
3.

Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital.

Richards MJ, Robertson MB, Dartnell JG, Duarte MM, Jones NR, Kerr DA, Lim LL, Ritchie PD, Stanton GJ, Taylor SE.

Med J Aust. 2003 Apr 21;178(8):386-90.

PMID:
12697010
4.

Enhanced in vivo sensitivity of in vitro interferon-treated B16 melanoma cells to CD8 cells and activated macrophages.

Fleischmann CM, Stanton GJ, Fleischmann WR Jr.

J Interferon Cytokine Res. 1996 Oct;16(10):805-12.

PMID:
8910765
5.

Modulation of immune responses by anabolic androgenic steroids.

Hughes TK, Fulep E, Juelich T, Smith EM, Stanton GJ.

Int J Immunopharmacol. 1995 Nov;17(11):857-63.

PMID:
8788115
6.

Production of interferon gamma messenger RNA by cells of non-immune origin.

Rady PL, Cadet P, Bui TK, Tyring SK, Baron S, Stanton GJ, Hughes TK.

Cytokine. 1995 Nov;7(8):793-8.

PMID:
8664446
7.

Enhanced in vivo sensitivity to interferon with in vitro resistant B16 tumor cells in mice.

Fleischmann CM, Stanton GJ, Fleischmann WR Jr.

Cancer Immunol Immunother. 1994 Sep;39(3):148-54.

PMID:
7923244
8.
9.

The interferons. Mechanisms of action and clinical applications.

Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, Hughes TK.

JAMA. 1991 Sep 11;266(10):1375-83. Review.

PMID:
1715409
10.

Modulation of peripheral leukocyte counts in mice by oral administration of interferons.

Fleischmann WR Jr, Fields EE, Wang JL, Hughes TK, Stanton GJ.

Proc Soc Exp Biol Med. 1991 Sep;197(4):424-30.

PMID:
1714606
11.

Anti-mouse IgM immunoglobulin protects weanling mice from Coxsackievirus infection.

Heard HK, Jordan C, Stanton GJ.

Microb Pathog. 1989 Dec;7(6):399-409.

PMID:
2560114
12.

Protection of mice from Semliki Forest virus infection by lymphocytes treated with low levels of interferon.

Stanton GJ, Lloyd RE, Sarzotti M, Blalock JE.

Mol Biother. 1989;1(6):305-10.

PMID:
2558683
13.

Immunoreactive ACTH, beta-endorphin, and cortisol levels in plasma following spinal manipulative therapy.

Christian GF, Stanton GJ, Sissons D, How HY, Jamison J, Alder B, Fullerton M, Funder JW.

Spine (Phila Pa 1976). 1988 Dec;13(12):1411-7.

PMID:
2850615
14.

Nondetectable levels of interferon gamma is a critical host defense during the first day of herpes simplex virus infection.

Stanton GJ, Jordan C, Hart A, Heard H, Langford MP, Baron S.

Microb Pathog. 1987 Sep;3(3):179-83.

PMID:
3143037
15.

Histamine releasing activity (HRA) produced by leukocytes co-cultured with tumor cells.

Langford MP, Lett-Brown MA, Stanton GJ, Grant JA.

Immunol Invest. 1987 Apr;16(2):129-38.

PMID:
2442099
16.

Interferon review.

Stanton GJ, Weigent DA, Fleischmann WR Jr, Dianzani F, Baron S.

Invest Radiol. 1987 Mar;22(3):259-73. Review.

PMID:
2435674
17.

Antibodies to the carboxyl terminus of mouse interferon-gamma neutralize its immunoregulatory and antiviral activities.

Langford MP, Weigent DA, Chan TS, Johnson HM, Stanton GJ.

J Interferon Res. 1987 Feb;7(1):95-101.

PMID:
3108419
18.
19.

Role of interferon in streptococcal infection in the mouse.

Weigent DA, Huff TL, Peterson JW, Stanton GJ, Baron S.

Microb Pathog. 1986 Aug;1(4):399-407.

PMID:
2469934
20.

Conjunctivitis in rabbits caused by enterovirus type 70 (EV70).

Langford MP, Yin-Murphy M, Barber JC, Heard HK, Stanton GJ.

Invest Ophthalmol Vis Sci. 1986 Jun;27(6):915-20.

PMID:
2423475
22.

Virus-specific, early appearing neutralizing activity and interferon in tears of patients with acute hemorrhagic conjunctivitis.

Langford MP, Barber JC, Sklar VE, Clark SW 3rd, Patriarca PA, Onarato IM, Yin-Murphy M, Stanton GJ.

Curr Eye Res. 1985 Mar;4(3):233-9.

PMID:
2410189
23.

Interferon-induced transfer of natural cytotoxic activity between human leukocytes.

Weigent DA, Blalock JE, Stanton GJ.

J Biol Response Mod. 1985 Feb;4(1):60-9.

PMID:
2580063
24.

The protective role of endogenous interferon in viral, bacterial, and protozoal infections.

Baron S, Weigent D, Stanton GJ, Peterson J.

Antiviral Res. 1985;Suppl 1:173-83. Review. No abstract available.

PMID:
3936412
25.

Eradication of cultured human melanoma cells by immune interferon and leukocytes.

Tyring SK, Klimpel G, Brysk M, Gupta V, Stanton GJ, Fleischmann WR Jr, Baron S.

J Natl Cancer Inst. 1984 Nov;73(5):1067-73.

PMID:
6436563
26.

Synergism of antiviral activity in cell cultures treated with low concentrations of interferon and interferon-treated lymphocytes.

Weigent DA, Lloyd RE, Blalock JE, Stanton GJ.

Proc Soc Exp Biol Med. 1984 Nov;177(2):257-61.

PMID:
6333028
27.

Interferon-induced transfer of viral resistance by human B and T lymphocytes.

Weigent DA, Langford MP, Stanton GJ, Blalock JE.

Cell Immunol. 1984 Sep;87(2):678-83.

PMID:
6088090
28.

Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture.

Peterman GM, Stanton GJ, Altman LC, Klimpel GR.

Cell Immunol. 1984 Apr 15;85(1):114-24.

PMID:
6201284
29.

Induction of human gamma interferon by structurally defined polypeptide fragments of group A streptococcal M protein.

Weigent DA, Beachey EH, Huff T, Peterson JW, Stanton GJ, Baron S.

Infect Immun. 1984 Jan;43(1):122-6.

30.

Antibodies to a synthetic peptide corresponding to the N-terminal end of mouse gamma interferon (IFN gamma).

Langford MP, Gray PW, Stanton GJ, Lakhchaura B, Chan TS, Johnson HM.

Biochem Biophys Res Commun. 1983 Dec 28;117(3):866-71.

PMID:
6421288
31.

Cell-to-cell transfer of interferon-induced antiproliferative activity.

Lloyd RE, Blalock JE, Stanton GJ.

Science. 1983 Sep 2;221(4614):953-5.

PMID:
6192500
32.

Ocular herpes simplex virus infection is diminished by depletion of B lymphocytes.

Jordan C, Baron S, Dianzani F, Barber J, Stanton GJ.

J Immunol. 1983 Sep;131(3):1554-7.

PMID:
6411818
33.

Interleukin 2 enhances natural killer cell activity through induction of gamma interferon.

Weigent DA, Stanton GJ, Johnson HM.

Infect Immun. 1983 Sep;41(3):992-7.

34.

Microassay for Sindbis virus and interferon activity.

Lloyd RE, Weigent DA, Stanton GJ.

J Clin Microbiol. 1983 Aug;18(2):296-9.

35.
36.

Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon.

Weigent DA, Langford MP, Fleischmann WR Jr, Stanton GJ.

Infect Immun. 1983 Apr;40(1):35-8.

37.

Recombinant gamma interferon enhances natural killer cell activity similar to natural gamma interferon.

Weigent DA, Stanton GJ, Johnson HM.

Biochem Biophys Res Commun. 1983 Mar 16;111(2):525-9. No abstract available.

PMID:
6404270
38.

Does an interferonopathy underlie a severe combined immunodeficiency disease (SCID) syndrome?

Jones JF, Minnich LM, Lucas DO, Langford MP, Stanton GJ.

Birth Defects Orig Artic Ser. 1983;19(3):109-14. No abstract available.

PMID:
6197104
39.

Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenesis.

Jones JF, Minnich LM, Lucas DO, Fulginiti VA, Ingham Z, Langford MP, Stanton GJ.

J Clin Immunol. 1983 Jan;3(1):14-21.

PMID:
6186684
40.

Neutralization of native human gamma interferon (HuIFN gamma) by antibodies to a synthetic peptide encoded by the 5' end of HuIFN gamma cDNA.

Johnson HM, Langford MP, Lakhchaura B, Chan TS, Stanton GJ.

J Immunol. 1982 Dec;129(6):2357-9.

PMID:
6183334
41.
43.

Inactivation of poliovirus by chloramine-T.

Gowda NM, Trieff NM, Stanton GJ.

Appl Environ Microbiol. 1981 Sep;42(3):469-76.

44.

Human B lymphocytes produce leukocyte interferon after interaction with foreign cells.

Weigent DA, Langford MP, Smith EM, Blalock JE, Stanton GJ.

Infect Immun. 1981 May;32(2):508-12.

45.

Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).

Langford MP, Weigent DA, Georgiades JA, Johnson HM, Stanton GJ.

J Immunol. 1981 Apr;126(4):1620-3.

PMID:
6162895
46.
47.

Cell types involved in production of interferon by leukocytes.

Stanton GJ, Langford MP, Weigent DA.

Tex Rep Biol Med. 1981-1982;41:84-8. No abstract available.

PMID:
6184837
48.

Transmission of IFN-induced activities by cell to cell communication.

Blalock JE, Baron S, Johnson HM, Stanton GJ.

Tex Rep Biol Med. 1981-1982;41:344-9.

PMID:
6184824
49.

Induction of interferon by bacteria, protozoa, and viruses: defensive role.

Baron S, Howie V, Langford M, Macdonald EM, Stanton GJ, Reitmeyer J, Weigent DA.

Tex Rep Biol Med. 1981-1982;41:150-7.

PMID:
6184800
50.

General considerations of the interferon system.

Baron S, Dianzani F, Stanton GJ.

Tex Rep Biol Med. 1981-1982;41:1-12. No abstract available.

PMID:
6184792

Supplemental Content

Loading ...
Support Center